Suchergebnisse - "YO603Y8113"

PubPharm (14)

1

Clinical Impact of Virological Failure and Resistance Analysis Definitions used in Pivotal Clinical Trials of Initial Antiretroviral Treatment : A Systematic Review

enthalten in: AIDS reviews | 2018

von Llibre, J. | Álvarez, H. | Yzusqui, M.

2

Tolerability of Current Antiretroviral Single-Tablet Regimens

enthalten in: AIDS reviews | 2018

von Domingo, P. | Mateo, M. | Gutierrez, M. | +1

3

Darunavir Stands Up as Preferred HIV Protease Inhibitor

enthalten in: AIDS reviews | 2017

von Mallolas, J.

4

Pharmacokinetics and Safety of Darunavir/Ritonavir in HIV-Infected Pregnant Women

enthalten in: AIDS reviews | 2017

von Khoo, S. | Peytavin, G. | Burger, D. | +5

5

Rezolsta® (Darunavir/Cobicistat) : First Boosted Protease Inhibitor Co-formulated with Cobicistat

enthalten in: AIDS reviews | 2015

von Curran, A. | Pérez-Valero, I. | Moltó, J.

6

Central nervous system penetration and effectiveness of darunavir/ritonavir monotherapy

enthalten in: AIDS reviews | 2014

von Pérez Valero, I. | González-Baeza, A. | Montes Ramírez, M.

7

Time to HIV-1 RNA suppression below 5 copies/ml during first-line protease inhibitor-based antiretroviral treatment - any impact of residual viremia on treatment success?

enthalten in: AIDS reviews | 2013

von Ripamonti, D. | Hill, A. | Lauthouwers, E. | +2

8

From TMC114 to darunavir : five years of data on efficacy

enthalten in: AIDS reviews | 2013

von Llibre, J. | Imaz, A. | Clotet, B.

9

Impact of hepatitis C co-infection on response to antiretroviral treatment

enthalten in: AIDS reviews | 2012

von Pulido, F. | Hill, A. | van Delft, Y. | +1

10

Protease inhibitors as preferred initial regimen for antiretroviral-naive HIV patients

enthalten in: AIDS reviews | 2011

von Tejerina, F. | Bernaldo de Quirós, J.